NCT00881101View on ClinicalTrials.gov

Clinical Study of Liposomal Paclitaxel in Chinese Patients

PHASE1UnknownINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

December 31, 2009

Conditions
Solid Tumor
Interventions
DRUG

Liposomal paclitaxel

All Patients will receive liposomal paclitaxel (starting at a dose of 190mg/m2,3h,ivgtt,at d1)each cycle for 1 cycle.

Trial Locations (1)

200032

The ethics committee of Cancer Hospital of Fudan University, Shanghai

Sponsors
All Listed Sponsors
lead

Nanjing Sike Pharmaceutical Co., Ltd.

INDUSTRY